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The rapid development of our understanding of the biologi- 
cal actions of nitric oxide (NO) has, to a large degree, been 
paralleled by our understanding of the enzyme responsi- 
ble for the synthesis of NO, nitric oxide synthase (NOS). 
The relatively fast pace of advance in NOS enzymology 
is primarily due to the fact that structure/function questions 
have crossed over several well-established enzymatic 
problems. As will be outlined below, NOS is a complex 
enzyme involving several tightly bound redox cofactors 
that are apparently organized into discrete domains that 
can be associated with a particular activity. First, the en- 
zyme has significant homology to NADPH cytochrome 
P-450 reductase and has been shown to contain a cyto- 
chrome P-450-type heme and to carry out P-450 chemistry 
in the formation of NO. What then is the relationship of 
NOS to the large class of cytochrome P-450 isoenzymes? 
Second, constitutive NOS isoforms require Ca*+ and cal- 
modulin (CaM) while inducible NOS (INOS) shows no re- 
quirement, although these isoforms apparently have CaM 
as a tightly bound subunit. What is the nature of this im- 
portant difference in the recognition and binding of CaM? 
NOS also has a tightly associated reduced pterin that is 
very important for an enzyme activity whose function is 
still not known. Third, the product of the reaction, NO, 
typically is a strong heme ligand. How is it that the enzyme 
escapes self-inactivation during turnover? These ques- 
tions shall be the main the focus of this review. 
General Characteristics of the Reaction 
The reaction catalyzed by NOS is illustrated in Figure 1. 
As shown, the reaction requires molecular oxygen (02) 
and reducing equivalents in the form of NADPH (Marletta, 
1993). Except for some minor structural modifications, all 
NOS isoforms specifically utilize L-arginine as the sub- 
strate. The products of the reaction are NO and citrulline 
(presumed to be the L-isomer). It is assumed, given the 
monooxygenase-like activity of NOS and the heavy iso- 
tope labeling studies, that H20 is the ultimate fate of the 
other oxygen atom. The initial NOS cDNA isolated was 
that of the neuronal isoform from rat cerebellum, where 
sequence analysis showed a significant homology of 
NADPH cytochrome P-450 reductase to the C-terminal 
sequence of this NOS isoform (Bredt et al., 1991). All 
clones isolated subsequently have demonstrated the 
same homology. Given that the normal function of this 
reductase is to supply reducing equivalents to cytochrome 
P-450, it has been assumed that this domain in NOS 
serves the same function. The findings that NOS also con- 
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tains a P-450-type heme moiety (see references in Mar- 
letta, 1993) and that this heme functions in the chemistry 
of the reaction (White and Marletta, 1992; Pufahl and Mar- 
letta, 1993) strengthen this hypothesis. 
Relationship to Cytochrome P-450 
Several laboratories have now shown with both inducible 
and constitutive isoforms that upon reduction and treat- 
ment with carbon monoxide, NOS shows a h,, of - 450 
nm. This relatively rare spectral characteristic is relegated 
to the large family of cytochrome P-450 enzymes. Most 
of the P-450s fall into a well-described supergene family 
whose function involves oxidative metabolism (hydroxyla- 
tion) of endogenous and xenobiotic compounds (Nelson 
et al., 1993). In addition, with one notable exception, the 
P-450s require a flavoprotein reductase and sometimes 
an iron-sulfur protein to transfer electrons into the heme 
prosthetic group that is responsible for the oxidative catal- 
ysis. The exception to this rule is a fatty acid monooxygen- 
ase, P-450~~3, isolated from Bacillus megaterium, where 
the flavoprotein reductase and the heme are contained 
within a single polypeptide (Narhi and Fulco, 1966). This 
P-450 has been called a self-sufficient P-450 since the 
need for a separate reductase is no longer necessary. 
NOS would appear to be the first self-sufficient mamma- 
lian P-450. However, comparison of NOS to the P45Os 
does not reveal any significant homology. This remains 
true even when the analyses are focused on the N-termi- 
nal domain where the heme site is located. The signature 
P-450 spectrum is derived from the ligation of a cysteine 
thiolate to the iron of the heme, and a lo-residue con- 
sensus sequence that includes this cysteine residue 
(FXXGXXXCXG) has been found in most of the P-450s 
characterized. As several groups have noted (McMillan et 
al., 1992; Renaud et al., 1993; White and Marletta, 1993), 
this lo-residue sequence is not present in NOS. However, 
several cysteines are conserved among the cloned NOS 
isoforms; alignment of some of those conserved cysteines 
with the P-450 consensus sequence is shown in Table 1. 
P-450,,, is a camphor hydroxylase isolated from Pseu- 
domonas putida, and P-450eM3 is the self-sufficient P-450 
fatty acid hydroxylase mentioned above. The conserved 
cysteine in NOS that provides the best alignment to this 
lo-residue P-450 sequence corresponds to neuronal NOS 
(nNOS) residues 409-417 and murine macrophage iNOS 
residues 166-196. In both cases, with a gap at position 
7, the alignment of the amino acid side chains of known 
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Table 1. Comparison of the Putative Heme-Binding Regions of NOS to Cytochrome P-450 
Relative Position 1 2 3 4 
P-450 consensus F X X G 
P-450,., F G H G 
P-45OBM3 F G N G 
nNOScwm w R N A 
nNOScm74j Y R C R 
iNOStfwloa, w R N A 
function determined from the crystal structure of P-450,,, 
(Poulos et al., 1987) is well conserved. Also shown in Table 
1 is the alignment of nNOS residues 886-674. C672 is 
conserved in the other NOS isoforms, and when nNOS is 
aligned with P-450eM3, C672 aligns with C401, the iron 
ligand in BM3. However, the rest of the sequence alignment 
is relatively poor. Further studies will be necessary before 
the cysteine ligand to the iron heme is definitively known. 
The fact that there is little other homology in the N-ter- 
minus when compared with the P-450s is not too surprising 
considering that the comparison is being made to en- 
zymes whose substrates are very hydrophobic molecules. 
The NOS substrate L-arginine is very hydrophilic, and 
NOS isoforms must have the appropriate residues to ac- 
commodate this substrate and any intermediates formed 
during the course of the reaction. Therefore, it appears 
that NOS lies outside the P-450 superfamily and has con- 
verged on using the P-450 chromophore for the chemistry 
that it carries out. In this regard NOS joins chloroperoxi- 
dase, allene oxide synthase, and thromboxane synthase 
as proteins that have the optical properties of P-450% but 
otherwise appear to be only distantly related. 
Mechanism of the Reaction 
As shown in Figure 1, the NOS reaction is known to involve 
an initial hydroxylation of L-arginine to generate NG-hydroxy- 
L-arginine (NHA) (Stuehr et al., 1991; Pufahl et al., 1992). 
This step presumably involves the heme moiety of NOS 
(White and Marletta, 1992; Pufahl and Marletta, 1993). 
Although the chemical steps involved in the conversion 
of NHA to NO and citrulline are not known, speculation 
based on enzymatic and chemical precedent has led to 
the proposal that the heme is directly involved in the oxida- 
tion of NHA (Marletta, 1993). This proposed mechanism 
involves a heme ferric peroxide (Fe(lll)-OO-) nucleophile 
as a key reaction intermediate. In addition, the mechanism 
proposes that NHA reduces the ferrous oxy-heme com- 
plex (Fe(ll)-02) to form Fe(lll)-OO- generating a radical 
species on the substrate that would ultimately become the 
odd electron radical on NO. Based on their determined 
oxidation potential of NHA, Korth et al. (1994) have pro- 
posed a slight, but important, modification to this mech- 
anism. 
NOS lsoforms 
A number of NOS isoforms have been purified from differ- 
ent tissues, and several more have been cloned and, in 
some cases, functionally expressed. Based on both se- 
quence analyses and biochemical studies, these NOS iso- 
5 6 7 8 9 10 
X X X C X G 
S H L c357 L G 
Q R A c401 I G 
S R - c415 V G 
G G - C672 P A 
P R - Cl94 I G 
forms are a quite closely related family of proteins, which 
are apparently the products of three distinct genes. In gen- 
eral, the synthases are grouped into two broad categories: 
a constitutive, Ca2+/CaM-dependent type that is involved 
in cellular signaling and an inducible isoform character- 
ized in macrophages and other cells that typically does 
not show a dependence on Ca2+/CaM. The first constitu- 
tive NOS isoforms purified were from rat and porcine cere- 
bellum (see references in Marletta, 1993; Nathan, 1992). 
These proteins, with reported monomeric M, values on 
SDS-polyacrylamide gels ranging from 150 to 160 kDa, 
are cytosolic and exist as homodimers under native condi- 
tions. A constitutive isoform (135 kDa on an SDS-poly- 
acrylamide gel) isolated from bovine vascular endothelium 
is distinct in that it is membrane bound (Pollock et al., 
1991). The cDNA-derived amino acid sequence of this en- 
dothelial cell NOS isoform shows a myristoylation consen- 
sus sequence at the N-terminus that is absent in the cyto- 
solic isoforms isolated from murine macrophages and rat 
cerebellum (Lamas et al., 1992). In addition, the bovine 
endothelial NOS sequence showed no transmembrane 
domain regions, suggesting that myristoylation is respon- 
sible for the membrane anchor of this NOS isoform, and 
subsequent studies convincingly showed that myristoyla- 
tion is critical for the membrane association of this isoform 
(Busconi and Michel, 1993). 
The inducible isoform purified from murine macro- 
phages is a cytosolic protein with a monomeric M, of 130 
kDa and, again, found to be dimeric under native condi- 
tions (Marletta, 1993). A sequence comparison shows that 
this isoform is about 500/o-60% identical to the cerebellar 
isoforms. In general, isoforms from the same tissue are 
essentially identical. For example, the sequence compari- 
son of the bovine endothelial to human endothelial shows 
them to be 95% identical (Marletta, 1993; Nathan and Xie, 
1994) whereas both of these isoforms show 500/o-60% 
identity to the macrophage-inducible isoform. The rat he- 
patocyteinducible isoform is essentially identical (96%) 
to the murine macrophage isoform. An interesting picture 
is emerging with regard to the comparison of inducible 
isoforms. Several human inducible isoforms have been 
cloned, including one from hepatocytes (Geller et al., 
1993) and one from a colorectal adenocarcinoma cell line 
(Sherman et al., 1993). These isoforms are essentially 
identical to each other (99%) with only a few amino acid 
differences. However, comparison of these inducible iso- 
forms to that from the murine macrophage shows about 
80% identity. In general, while all human isoforms are 
essentially identical to each other regardless of the origin 
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Constitutive lsoforms Figure 2. Interactions of CaM with NOS 
The constitutive isoforms show a typical inter- 
action in which CaM-NOS complex formation 
is controlled by Ca*+. The inducible isoforms, 
especially those from murine macrophages, 
form a very tight complex at low levels of Ca*. 
Inducible lsoforms 
of the tissue, significant differences exist when compared 
with inducible rodent isoforms. A truncated mRNA coding 
for the rat cerebellar NOS has been isolated; however, 
the significance of this finding is not clear, especially since 
the region missing comes about from an in-frame deletion 
of two exons. These exons are from a highly conserved 
region and likely represent an important part of the sub- 
strate or reduced pterin-binding site. 
Ca*+/CaM Dependence of NOS 
The activity of the constitutive NOS isoforms is strictly 
controlled by Ca= and CaM, and while other mechanisms 
of activity regulation, particularly for the particulate endo- 
thelial form, are being investigated (Nathan and Xie, 1994), 
control of these isoforms by regulation of intracellular Ca’+ 
levels represents a critical point of control (see Figure 2). 
CaM recognition sequences have been found in all NOS 
isoforms (Lowenstein and Snyder, 1992). Since the consti- 
tutive forms showed a dependence on Cd+/CaM, it was 
expected that a sequence of this type would be present. 
However, it was not clear why this sequence would be 
present in the iNOS isoforms until it was shown that the 
iNOS isolated from murine macrophages appears to co- 
purify with a tightly bound CaM subunit (Nathan and Xie, 
1994). In hindsight it appears that this particular inducible 
isoform from murine macrophages is at the extreme in the 
ability to bind CaM in that other inducible isoforms show 
some level of inhibition after treatment with Ca2+ chelating 
agents, CaM antagonists, or both (see references in Mar- 
letta, 1994). This unusual protein-CaM interaction and the 
role of Ca2+ in this binding clearly deserve further attention. 
The potential role of Ca2+/CaM in the NOS reaction has 
recently received some attention. Titration of the neuronal 
constitutive isoform with Ca2+/CaM led to quenching of the 
intrinsic fluorescence of the protein, suggestive of a con- 
formational change upon complex formation (Sheta et al., 
1994). The implication is that this conformational change 
allows for efficient electron transfer and catalysis. That 
Ca2+/CaM binding is critical for electron transfer is sup- 
ported by the finding that showed that the rate of NADPH 
oxidation for the neuronal isoform is primarily influenced 
by CaVCaM and not L-arginine (Abu-Soud and Stuehr, 
1993). However, the rate of NADPH oxidation by murine 
macrophage iNOS is measurable without substrate and 
increases in the presence of L-arginine (Abu-Soud and 
Stuehr, 1993). The results would suggest that the constitu- 
tive isoforms would reduce 02 in the absence of substrate 
generating superoxide (02-) and hydrogen peroxide (H*O*) 
coincident with Ca2+/CaM-NOS complex formation, 
whereas the inducible isoform would generate 02- and 
H202 at some basal level, which would increase and be- 
come coupled to product formation in the presence of sub- 
strate. Given the dependence of reduction rates (NADPH 
oxidation) in P-450~ on heme spin state and the known 
influence of substrate on this parameter, and the known 
effect of tetrahydrobiopterin on the spin state, the conclu- 
sions reached thus far about the role of Ca2+/CaM in the 
NOS reaction are likely to be oversimplifications. 
Potential for End Product Inhibition 
NO has long been known and used, especially in inorganic 
chemistry, as a ligand in iron-heme complexes. These 
studies include heme-NO complexes of chemical model 
compounds and hemoprotein-NO complexes. The possi- 
bility has been raised that the NO derived from NOS could 
inhibit subsequent turnover of the enzyme (Rengasamy and 
Johns, 1993; Rogers and Ignarro, 1992). The ability of NO 
to form a relatively stable complex with both ferric and 
ferrous P-450 hemes has been established a number of 
years ago; however, the complexes were unstable in the 
presence of oxygen. Stable heme-NO complexes are typi- 
cally formed with hemoproteins such as hemoglobin 
where the ligand to the heme is histidine and not cysteine, 
as in P-450 and NOS. The potential of NO to inhibit NOS 
under physiological conditions is still an open question; 
however, the chemistry of NO interaction with a P-QSO-type 
heme and the reactivity of NO with ferrous oxy-heme com- 
plexes such as hemoglobin argues against this potential 
mode of inhibition. Further characterization of the stability 
of NOS-NOcomplexes will be needed before thisquestion 




The reaction catalyzed by NOS involves some unusual 
chemistry, and the enzyme seems to have evolved with 
pieces of previously characterized proteins that, when fit- 
ted together, allow for the efficient synthesis of a key mo- 
lecular signaling agent on the one hand and an apparent try 31, 6822-6828 
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